These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2676149)

  • 1. Pharmacokinetics of diastereoisomers of (6R,S)-folinic acid (leucovorin) in humans during constant high-dose intravenous infusion.
    Newman EM; Straw JA; Doroshow JH
    Cancer Res; 1989 Oct; 49(20):5755-60. PubMed ID: 2676149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and toxicity of continuous infusion (6S)-folinic acid and bolus 5-fluorouracil in patients with advanced cancer.
    Newman EM; Akman SA; Harrison JS; Leong LA; Margolin KA; Morgan RJ; Raschko JW; Somlo G; Ahn CW; Doroshow JH
    Cancer Res; 1992 May; 52(9):2408-12. PubMed ID: 1568210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology and phase I trial of high-dose oral leucovorin plus 5-fluorouracil in children with refractory cancer: a report from the Children's Cancer Study Group.
    Patel R; Newman EM; Villacorte DG; Sato JK; Reaman GH; Finklestein JZ; Krailo MD; Hammond GD; Holcenberg JS
    Cancer Res; 1991 Sep; 51(18):4871-5. PubMed ID: 1893377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorouracil combined with the pure (6S)-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma: a phase I-II study.
    Machover D; Grison X; Goldschmidt E; Zittoun J; Lotz JP; Metzger G; Richaud J; Hannoun L; Marquet J; Guillot T
    J Natl Cancer Inst; 1992 Mar; 84(5):321-7. PubMed ID: 1738182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of fluorouracil and folinic acid.
    Schalhorn A; Kühl M
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):82-92. PubMed ID: 1557660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of high-dose leucovorin calcium after intravenous and oral administration.
    Schilsky RL; Ratain MJ
    J Natl Cancer Inst; 1990 Sep; 82(17):1411-5. PubMed ID: 2388292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of reduced folates after intraperitoneal and intravenous administration of racemic [6S,R]-folinic acid.
    Sips JH; van Tellingen O; Nooijen WJ; Rodenhuis S; Ten Bokkel Huinink WJ; Beijnen JH
    Cancer Chemother Pharmacol; 1994; 35(2):144-8. PubMed ID: 7987991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II and pharmacokinetic study of 6S-leucovorin plus 5-fluorouracil in patient with colorectal carcinoma.
    Meropol NJ; Petrelli NJ; Rustum YM; Rodriguez-Bigas M; Blumenson LE; Frank C; Berghorn E; Creaven PJ
    Invest New Drugs; 1995; 13(2):149-55. PubMed ID: 8617578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of reduced folates after short-term infusion of d, 1-folinic acid.
    Schalhorn A; Kühl M; Stupp-Poutot G; Nüssler V
    Cancer Chemother Pharmacol; 1990; 25(6):440-4. PubMed ID: 2311173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic analysis of (6S)-5-formyltetrahydrofolate (1-CF), (6R)-5-formyltetrahydrofolate (d-CF) and 5-methyltetrahydrofolate (5-CH3-THF) in patients receiving constant i.v. infusion of high-dose (6R,S)-5-formyltetrahydrofolate (leucovorin).
    Straw JA; Newman EM
    Adv Exp Med Biol; 1988; 244():53-8. PubMed ID: 3266829
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of diastereoisomers of 5-formyltetrahydrofolate on cellular growth, sensitivity to 5-fluoro-2'-deoxyuridine, and methylenetetrahydrofolate polyglutamate levels in HCT-8 cells.
    Zhang ZG; Rustum YM
    Cancer Res; 1991 Jul; 51(13):3476-81. PubMed ID: 2054787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary analysis of a randomized comparison of 5-fluorouracil versus 5-fluorouracil and high-dose continuous-infusion folinic acid in disseminated colorectal cancer.
    Doroshow JH; Bertrand M; Newman E; Multhauf P; Leong L; Blayney D; Goldberg D; Margolin K; Carr B; Akman S
    NCI Monogr; 1987; (5):171-4. PubMed ID: 3501538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and in vitro studies of l-leucovorin. Comparison with the d and d,l-leucovorin.
    Zittoun J
    Ann Oncol; 1993; 4 Suppl 2():1-5. PubMed ID: 8353099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of leucovorin (D,L-5-formyltetrahydrofolate) after intravenous injection and constant intravenous infusion.
    Straw JA; Newman EM; Doroshow JH
    NCI Monogr; 1987; (5):41-5. PubMed ID: 3501545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of 5-fluorouracil (5-FUra) in patients with metastatic colorectal cancer receiving 5-FUra bolus plus continuous infusion with high dose folinic acid (LV5FU2).
    Joulia JM; Pinguet F; Ychou M; Duffour J; Topart D; Grosse PY; Astre C; Bressolle F
    Anticancer Res; 1997; 17(4A):2727-30. PubMed ID: 9252705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Continuous double administration of 5 fluorouracil (intravenous and intraperitoneal) modulated by folinic acid: phase I clinical study and pharmacokinetics in patients with intra-abdominal developing cancers].
    de Forni M; Gualano V; Canal P; Martel P; Izar-Soum F; Chevreau C; Soulié P; Roché H; Bugat R
    Bull Cancer; 1993 May; 80(5):408-17. PubMed ID: 8173194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of thymidylate synthase by the diastereoisomers of leucovorin.
    Lee PP; Schilsky RL
    Cancer Chemother Pharmacol; 1990; 26(4):273-7. PubMed ID: 2114950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I trial of dipyridamole with 5-fluorouracil and folinic acid.
    Budd GT; Jayaraj A; Grabowski D; Adelstein D; Bauer L; Boyett J; Bukowski R; Murthy S; Weick J
    Cancer Res; 1990 Nov; 50(22):7206-11. PubMed ID: 2224854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between dose rate of [6RS]Leucovorin administration, plasma concentrations of reduced folates, and pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon adenocarcinoma xenografts.
    Houghton JA; Williams LG; de Graaf SS; Cheshire PJ; Rodman JH; Maneval DC; Wainer IW; Jadaud P; Houghton PJ
    Cancer Res; 1990 Jun; 50(12):3493-502. PubMed ID: 2140289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of dose of [6RS]leucovorin on reduced folate pools and 5-fluorouracil-mediated thymidylate synthase inhibition in human colon adenocarcinoma xenografts.
    Houghton JA; Williams LG; Cheshire PJ; Wainer IW; Jadaud P; Houghton PJ
    Cancer Res; 1990 Jul; 50(13):3940-6. PubMed ID: 2354443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.